← Leaderboards
Naim M Maalouf
University Of Texas Sw Med Ctr/Dallas
$8,442,081
Attributed
$10,296,098
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,296,098 · 5
By mechanism
U01$5,346,065 · 1
R01$3,937,404 · 2
K23$582,335 · 1
R21$430,294 · 1
Top collaborators
- Orson W Moe5 shared
- Khashayar Sakhaee5 shared
- Ming-Chang Hu4 shared
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Charles Y.c Pak$11,557,463
- Khashayar Sakhaee$14,492,169
- Margaret S. Pearle$3,288,901
- Orson W Moe$15,748,560
- Howard J Heller$2,980,605
Others in their field
Top investigators on “Nephrolithiasis”
- John C Lieske · University Of Chicago$12,169,224
- Joseph R Hume · University Of Nevada Reno$9,222,880
- Lawrence John Appel · Johns Hopkins University$7,762,016
- Khashayar Sakhaee · University Of Texas Sw Med Ctr/Dallas$6,566,285
- Gary C. Curhan · Brigham And Women'S Hospital$5,125,178
- Andrew P Evan · Indiana Univ-Purdue Univ At Indianapolis$5,079,076
Research focus
NephrolithiasisKidneyPreventionUrineKidney CalculiUrinaryRegimenRecurrenceMetabolicCalciumBaseAlkaliesPreventExcretory FunctionPrevalenceResearch PersonnelParticipantClinical ResearchUrinary CalculiBody Weight DecreasedSafetyIntakeLiquid SubstancePlacebos
Grant awards (23)
Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones$471,750
R01 · FY2025 · DK · contact PI
Fluid Therapy and Stent Management in Nephrolithiasis, USDRN extension$479,998
U01 · FY2024 · DK · contact PI
Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones$452,882
R01 · FY2024 · DK · contact PI
Fluid Therapy and Stent Management in Nephrolithiasis, USDRN extension$596,122
U01 · FY2023 · DK · contact PI
Pathogenesis of Uric Acid Nephrolithiasis$502,962
R01 · FY2023 · DK
Hydroxycitrate: A Novel Therapy for Calcium Phosphate Urinary Stones$484,864
R01 · FY2023 · DK · contact PI
Fluid Therapy and Stent Management in Nephrolithiasis, USDRN extension$655,872
U01 · FY2022 · DK · contact PI
Pathogenesis of Uric Acid Nephrolithiasis$510,253
R01 · FY2022 · DK
Pathogenesis of Uric Acid Nephrolithiasis$508,607
R01 · FY2021 · DK
Optimizing Fluid Therapy and Stent Management in Children and Adults with Nephrolithiasis$704,141
U01 · FY2020 · DK · contact PI
Pathogenesis of Uric Acid Nephrolithiasis$505,438
R01 · FY2020 · DK
Optimizing Fluid Therapy and Stent Management in Children and Adults with Nephrolithiasis$804,445
U01 · FY2019 · DK · contact PI
Pathogenesis of Uric Acid Nephrolithiasis$500,648
R01 · FY2019 · DK
Optimizing Fluid Therapy and Stent Management in Children and Adults with Nephrolithiasis$661,602
U01 · FY2018 · DK · contact PI
Optimizing Fluid Therapy and Stent Management in Children and Adults with Nephrolithiasis$723,128
U01 · FY2017 · DK · contact PI
Optimizing Fluid Therapy and Stent Management in Children and Adults with Nephrolithiasis$720,757
U01 · FY2016 · DK · contact PI
Pharmacological Therapy for Calcium Phosphate Urolithiasis$191,794
R21 · FY2013 · DK · contact PI
Pharmacological Therapy for Calcium Phosphate Urolithiasis$238,500
R21 · FY2012 · DK · contact PI
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AWARD$116,467
K23 · FY2009 · RR · contact PI
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AWARD$116,467
K23 · FY2008 · RR · contact PI
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AWARD$116,467
K23 · FY2007 · RR · contact PI
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AWARD$116,467
K23 · FY2006 · RR · contact PI
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AWARD$116,467
K23 · FY2005 · RR